<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03405753</url>
  </required_header>
  <id_info>
    <org_study_id>Lab.Reprod.Biol.-Aronia</org_study_id>
    <nct_id>NCT03405753</nct_id>
  </id_info>
  <brief_title>Potential Health Effects of Aronia Intake</brief_title>
  <official_title>Effects of Aronia Berry on Oxidative Stress, Cholesterol, Blood Pressure and Semen Quality</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Odense University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intervention cross-over study during which participants receive standardized amounts of
      aronia berry tablets or placebo for three months, then wash out for three months, then aronia
      tablets or placebo for three months. The potential health effects are investigated. Following
      parameters are measured before and after each period of tablet intake: 1) Blood pressure, 2)
      Lipid fractions, 3) Testosterone, 4) Phase II markers, 5) HbA1c, 6) HSCRP, 7)
      F2-isoprostanes, and 8) semen quality.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cholesterol</measure>
    <time_frame>9 months</time_frame>
    <description>HDL, LDL and total cholesterol in mmol/L</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Phase II enzyme activity</measure>
    <time_frame>9 months</time_frame>
    <description>Glutathion in U/mL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phase II enzyme activity</measure>
    <time_frame>9 months</time_frame>
    <description>Superoxid dismutase (SOD) in U/mL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phase II enzyme activity</measure>
    <time_frame>9 months</time_frame>
    <description>Catalase (CAT) in U/mL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Isoprostanes</measure>
    <time_frame>9 months</time_frame>
    <description>Peroxidation of fatty acids measured in U/mL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Semen quality</measure>
    <time_frame>9 months</time_frame>
    <description>Sperm count in million/mL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Semen quality</measure>
    <time_frame>9 months</time_frame>
    <description>Motility in percent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Semen quality</measure>
    <time_frame>9 months</time_frame>
    <description>DNA fragmentation in percent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>9 months</time_frame>
    <description>Systolic and diastolic blood pressure in mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High Sensitivity C reactive protein</measure>
    <time_frame>9 months</time_frame>
    <description>Acute phase reactant in mg/L</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Health Effects of Aronia</condition>
  <arm_group>
    <arm_group_label>Aroia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Aronia, washout and then placebo</intervention_name>
    <description>Three tablets three times à day for three months then washout for three months, then three placebo tablets three times à day for three months. Blood samples and semen samples collected before and after each period of tablet intake.</description>
    <arm_group_label>Aroia</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo, washout and then aronia</intervention_name>
    <description>Three tablets three times à day for three months, then washout for three months, then three aronia tablets three times à day for three months. Blood samples and semen samples collected before and after each period of tablet intake.</description>
    <arm_group_label>Aroia</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy men with total cholesterol between 5 and 7 mmol/L, who do not take medication

        Exclusion Criteria:

          -  Chronic diseases and intake of medication or antioxidants
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Maja DK Fedder, PhD</last_name>
    <phone>+45 40434045</phone>
    <email>maja.doevling@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jens Fedder, Professor</last_name>
    <phone>26820368</phone>
    <email>jens.fedder@rsyd.dk</email>
  </overall_contact_backup>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 5, 2018</study_first_submitted>
  <study_first_submitted_qc>January 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 23, 2018</study_first_posted>
  <last_update_submitted>January 12, 2018</last_update_submitted>
  <last_update_submitted_qc>January 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Odense University Hospital</investigator_affiliation>
    <investigator_full_name>Jens Fedder</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

